Mahrshee Laboratories

Manufacturing of bulk drugs, drug intermediates, and speciality chemicals in India.

About Mahrshee Laboratories

Mahrshee Laboratories is a Healthcare company. Manufacturing of bulk drugs, drug intermediates, and speciality chemicals in India. It operates in the Healthcare and Chemicals & Materials sectors. The company has 22 employees. Its Indian entity Mahrshee Laboratories Private Limited reported revenue of β‚Ή34.56 Cr. Mahrshee Laboratories offers products and services including Bulk Drugs and Drug Intermediates. Its focus areas include Healthcare and Pharmaceuticals, Pharmaceuticals, API Manufacturing and Bulk Drugs.

Company details

Mahrshee Laboratories is identified as a manufacturer of bulk drugs, drug intermediates, and speciality chemicals, primarily located in Bharuch, Gujarat, India. Various antihistaminics, antifungals, and intermediates like œ-Phenyl-2-Pyridyl Acetonitrile are produced under quality control and RD processes. The company supplies these products for pharmaceutical applications, with facilities that support packing and distribution. Contact is facilitated through provided email and phone channels, ensuring operational accessibility. Emphasis is placed on compliance with standards in the healthcare and chemicals sectors.

  • Employees 22
  • Sectors
    Healthcare
    Chemicals & Materials
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website mahrsheelab.com
  • Legal Name Mahrshee Laboratories Pvt. Ltd.
  • Date of Incorporation 19 Aug, 1998
  • Jurisdiction Panoli, Gujarat, India
Key Metrics
  • Indian entity revenue
    ₹34.56 Cr

    FY 2025 · -8% YoY

  • Indian entity net profit
    ₹1.51 Cr

    FY 2025 · 4% margin

  • Indian entity EBITDA
    ₹2.96 Cr

    FY 2025 · 9% margin

  • Employee Count
    22

Products & Services of Mahrshee Laboratories

Mahrshee Laboratories offers a comprehensive portfolio of products and services, including Bulk Drugs and Drug Intermediates.

Bulk Drugs
Pharmaceuticals

Bulk drugs including antihistaminics and antifungals are manufactured for medicinal purposes.

Drug Intermediates
Chemical Intermediates

Drug intermediates such as various piperazines and acetonitriles are produced for pharmaceutical applications.

Board of directors of Mahrshee Laboratories Private Limited (Mahrshee Laboratories)

Mahrshee Laboratories Private Limited is the primary company behind Mahrshee Laboratories. The board of Mahrshee Laboratories Private Limited currently have 3 directors; the longest-serving is Vinubhai Mohanbhai Dobaria, appointed in 1998. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Vinubhai Mohanbhai Dobaria
DIN 00185660
Director19 Aug 199828 yrs 2 moMahrshee Laboratories Private Limited
Jayantibhai Gangjibhai Patel
DIN 02576872
Director19 Nov 199827 yrs 11 moMahrshee Laboratories Private Limited
Mukeshkumar Dahyabhai Patel
DIN 02574213
Director11 Dec 200025 yrs 10 moMahrshee Laboratories Private Limited

Financials of Mahrshee Laboratories

Figures of Mahrshee Laboratories Private Limited, the primary company behind Mahrshee Laboratories, for FY 2025. Revenue was ₹34.56 Cr (-8% year on year). Net profit was ₹1.51 Cr (4% margin). EBITDA was ₹2.96 Cr (9% margin). Revenue has grown at a compounded annual rate of -3% over three years and 0% over five years.

  • ₹34.56 CrRevenue · FY 2025 · -8% YoY
  • ₹1.51 CrNet profit · 4% margin
  • ₹2.96 CrEBITDA · 9% margin
  • ₹83.9 LakhPaid-up capital
  • 22Employees (provident fund records)
  • -3%Revenue CAGR, 3 years
  • 0%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Mahrshee Laboratories Private Limited are on its company page.

Premium access

Detailed financial statements for Mahrshee Laboratories

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Mahrshee Laboratories

Mahrshee Laboratories has 22 employees.

The primary company behind Mahrshee Laboratories, Mahrshee Laboratories Private Limited, reported revenue of β‚Ή34.56 Cr for FY 2025, down 8% year on year.

Mahrshee Laboratories is identified as a manufacturer of bulk drugs, drug intermediates, and speciality chemicals, primarily located in Bharuch, Gujarat, India. Various antihistaminics, antifungals, and intermediates like Ε“-Phenyl-2-Pyridyl Acetonitrile are produced under quality control and RD processes. The company supplies these products for pharmaceutical applications, with facilities that support packing and distribution. Contact is facilitated through provided email and phone channels, ensuring operational accessibility. Emphasis is placed on compliance with standards in the healthcare and chemicals sectors.

Mahrshee Laboratories offers Bulk Drugs and Drug Intermediates.

Mahrshee Laboratories operates through Mahrshee Laboratories Private Limited.

The legal entities of Mahrshee Laboratories currently have 3 directors, including Mukeshkumar Dahyabhai Patel, Vinubhai Mohanbhai Dobaria, Jayantibhai Gangjibhai Patel.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available